IST5-002 is a small molecule inhibitor that prevents both JAK2 and BCR-ABL-mediated phosphorylation of STAT5 and induces apoptosis in prostate cancer and chronic myeloid leukemia [82]. Here, STAT5B is linked to prostate carcinoma.